1. Home
  2. MG vs ESPR Comparison

MG vs ESPR Comparison

Compare MG & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

HOLD

Current Price

$13.24

Market Cap

309.4M

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.94

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MG
ESPR
Founded
1978
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
309.4M
898.5M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
MG
ESPR
Price
$13.24
$3.94
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$6.67
AVG Volume (30 Days)
195.8K
6.5M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
60.33
N/A
EPS
0.57
N/A
Revenue
$715,300,000.00
$303,802,000.00
Revenue This Year
$1.46
$25.45
Revenue Next Year
$3.61
N/A
P/E Ratio
$22.87
N/A
Revenue Growth
N/A
2.83
52 Week Low
$7.06
$0.69
52 Week High
$13.43
$4.13

Technical Indicators

Market Signals
Indicator
MG
ESPR
Relative Strength Index (RSI) 67.31 59.26
Support Level $12.20 $3.63
Resistance Level $13.05 $4.13
Average True Range (ATR) 0.49 0.20
MACD 0.06 -0.02
Stochastic Oscillator 93.76 59.00

Price Performance

Historical Comparison
MG
ESPR

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: